Neurológia pre prax 4/2025
Initiation of cenobamate treatment in a patient with psychiatric comorbidity and reduced compliance
Pharmacoresistant epilepsy represents a third of patients treated for epilepsy. Despite treatment with multiple anticonvulsant drugs, the condition is not compensated and epileptic seizures persist. The problem of treatment is also the patient’s noncompliance and psychiatric comorbidities. By using new anticonvulsant drugs, it is possible to achieve compensation of the disease and improve patient compliance and maintain the patient on the prescribed treatment, without worsening psychiatric comorbidity.
Keywords: pharmacoresistant epilepsy, cenobamate, noncompliance